Nyhetsbyrån Direkt about Cinclus Pharma
ABOUT 80-90% OF THE POTENTIAL FOR LINAPRAZAN GLURATE IN THE US
Read more
News
Check out the latest news from Cinclus Pharma
Cinclus Pharma at Stora Aktiedagarna
Watch CEO Christer Ahlberg's presentation from Stora Aktiedagarna in Stockholm, organized by Aktiespararna.
Read more
Watch the presentation from Redeye Investor Forum October 10th
Here, you can watch the full presentation (in Swedish) by CEO of Cinclus Pharma, Christer Ahlberg, from Redeye AB Investor Forum October 10th, on the company and the development of linaprazan glurate.
Read more